TRAW
Traws Pharma
$0.52
+$0.03 (+6.56%)Jul 27, 2026
Key metrics
The numbers that frame TRAW today
- Market cap
- $7.88M
- P/E (TTM)
- -0.5
- EV / FCF
- -0.3
- Gross margin
- 100%
- EV / Sales
- 1.7
- ROIC
- 220.2%
- Div yield
- 0%
- 52wk Low
- $0.46
- 52wk High
- $3.27
Growth
Revenue and earnings trend for TRAW
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TRAW
Is Traws Pharma a good buy?
No. Traws Pharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Traws Pharma is selling at a very high price.
What is the market capitalization of TRAW?
Traws Pharma's market capitalization is $7.88M.
What is the P/E ratio for TRAW stock?
Traws Pharma's current P/E ratio is -0.5.
What is the 52-week high for TRAW stock?
The 52-week high for Traws Pharma is $3.27. The current close of $0.52 is 84.1% below that high.
What is the 52-week low for TRAW stock?
The 52-week low for Traws Pharma is $0.46. The current close of $0.52 is 13.8% above that low.
Does TRAW stock pay dividends?
Traws Pharma does not currently show a dividend per share in the company data.